Does tribulus raise testosterone or improve libido and erections?

The primary active compounds are steroidal saponins, particularly protodioscin, concentrated in the fruit and leaves. These saponins don't directly raise testosterone the way many labels claim — that oversimplification has given the herb a reputation for overpromising.

What the research actually supports is more nuanced:

Nitric oxide enhancement. The most evidence-backed mechanism is stimulation of nitric oxide release from endothelial cells and nitrergic nerve endings. Nitric oxide relaxes smooth muscle in blood vessels, including penile tissue — the same pathway targeted by pharmaceutical ED medications. This appears to be the dominant mechanism behind tribulus's effects on erectile function.²

Hormonal modulation in deficiency states. Studies in men with partial androgen deficiency (low-normal testosterone) and in premenopausal women have shown modest increases in testosterone levels. However, multiple trials in healthy men with normal testosterone found no significant change. The herb may support hormonal balance when output is already impaired, but it is not a testosterone booster for healthy men.^1,4

Androgen sensitivity. Some research suggests protodioscin may enhance sensitivity to existing androgens rather than increasing their production — a subtly different mechanism with similar practical effects.

Dosage and Forms

Clinical trials have used doses ranging from 250–750 mg of standardized extract per day, typically taken in two or three divided doses. Look for extracts standardized to 40–45% saponins (expressed as protodioscin). Bulgarian tribulus (Tribulus terrestris L.) is the form most studied in clinical trials; quality varies widely between manufacturers.

Most trials run for 4–12 weeks. Safety data beyond three months is limited, so cycling use is reasonable — four to eight weeks on, several weeks off.

Who It May Help

• Men with mild to moderate erectile dysfunction, particularly when linked to reduced androgen activity
• Women experiencing low libido or sexual arousal difficulty, including postmenopausal women
• Men with documented low-normal testosterone (late-onset hypogonadism)

Who Should Use Caution

Tribulus is not appropriate for men with prostate conditions. One trial noted a small but significant rise in PSA (prostate-specific antigen) levels, and slight liver enzyme elevation (AST) was observed. Anyone with prostate cancer, BPH, or liver disease should avoid it without medical guidance.⁴

It is also not recommended during pregnancy or breastfeeding, as the saponin content has shown uterine-stimulating activity in animal models.

See our Tongkat Ali page for another herb with testosterone-supporting effects, and the Maca Root page for hormonal adaptogen support relevant to women.

Systematic Review: Testosterone and Erectile Dysfunction in Men (Vilar Neto et al., 2025)

A 2025 systematic review in Nutrients analyzed 10 clinical trials enrolling 483 men aged 16–70 with erectile dysfunction. Tribulus doses ranged from 400–750 mg/day over 1–3 months.¹

On testosterone: eight of ten studies found no statistically significant change in serum testosterone. Two studies did show increases of approximately 60–70 ng/dL, but exclusively in men with baseline hypogonadism. The authors concluded there is "no robust evidence" for testosterone elevation in healthy men and that marketing claims remain "unsubstantiated" by the current clinical evidence base.

On erectile function: three of five studies assessing this outcome found significant improvement on validated scales (primarily the International Index of Erectile Function, IIEF). The overall assessment was "low level of evidence regarding effectiveness" — meaningful enough to keep investigating, but not yet at the level where strong recommendations can be made.

Safety across the included trials was generally favorable, with no significant difference in adverse events between treatment and placebo arms.

Randomized Controlled Trial: Male Sexual Dysfunction (Kamenov et al., 2017)

A well-designed double-blind RCT published in Maturitas enrolled 180 men aged 18–65 with mild to moderate erectile dysfunction, with or without hypoactive sexual desire disorder.² After 12 weeks, men receiving tribulus showed a mean improvement of 2.70 points on the IIEF score compared to placebo (p < 0.0001). This is a clinically modest but statistically robust difference. The treatment was well tolerated with no drug-related serious adverse events.

The authors propose that the benefit operates primarily through nitric oxide pathways rather than hormonal ones — meaning tribulus may improve erectile function through vascular rather than endocrine mechanisms.

Systematic Review: Female Sexual Dysfunction (Martimbianco et al., 2020)

Five RCTs with 279 female participants (premenopausal and postmenopausal) were analyzed in a 2020 systematic review in Revista Brasileira de Ginecologia e Obstetrícia.³ Both premenopausal and postmenopausal women showed significant increases in standardized sexual function scores. Premenopausal women also showed a statistically significant increase in serum testosterone levels after three months.

The authors assigned a "very low certainty of evidence" rating, primarily due to small sample sizes and heterogeneous outcome measures. Adverse events were minimal across all included trials. The reviewers recommend shared decision-making between patients and clinicians given the early-stage nature of the evidence.

Placebo-Controlled Study: Late-Onset Hypogonadism (GamalEl Din et al., 2019)

A 2019 trial in Urologia specifically enrolled 70 aging men with testosterone in the low-normal range and existing erectile dysfunction.⁴ After three months of tribulus supplementation, the treatment group showed significant increases in total testosterone (p < 0.001) and meaningful improvement on the Arabic Index of Erectile Function (baseline mean 10.7 rising to 16.1, p < 0.001). Lower urinary tract symptoms did not worsen.

Notably, this trial detected a small but statistically significant elevation in AST liver enzyme (26.5 to 27.8, p = 0.03) and PSA (1.4 to 1.7, p = 0.007). Neither value crossed into clinical concern in healthy subjects, but the PSA signal warrants caution in men with prostate risk factors.

Infertility Trial: No Benefit Detected (Roaiah et al., 2016)

A trial at Cairo University enrolled 30 men with idiopathic infertility and administered 750 mg/day of tribulus extract in divided doses for three months.⁵ No statistically significant improvements were found in sperm concentration, motility, or morphology, and testosterone levels were unchanged. This null result is important context: tribulus does not appear to be an effective treatment for male infertility, which is a distinct clinical condition from erectile dysfunction.

Overall Evidence Assessment

The picture that emerges from current clinical evidence is specific: tribulus terrestris shows genuine promise for sexual dysfunction — modest erectile improvement in men and libido support in women — likely through nitric oxide and androgen-sensitizing mechanisms rather than direct testosterone production. Claims of meaningful testosterone elevation in healthy individuals are not well supported. Evidence quality across studies remains low to moderate, with small sample sizes and short durations as recurring limitations. For individuals with documented low-normal testosterone or mild sexual dysfunction, tribulus represents a reasonable low-risk option worth discussing with a healthcare provider.